(1)
Estimating the Budget Impact of Innovative Pharmacological Treatments for Patients With Type 2 Diabetes Mellitus in Italy: The Case of Liraglutide (GLP-1). . ebph 2022, 12 (2). https://doi.org/10.2427/11082.